Accelrys, Inc., a provider of scientific innovation lifecycle management software, today announced the new integrated Accelrys Process Management and Compliance Suite of software products designed specifically to enhance product and process insight, facilitate collaboration and streamline product development from research through late-stage quality control and manufacturing. By improving the way businesses manage the scientific innovation lifecycle, the suite aims to help companies bring products to market faster and at a lower cost, while meeting critical quality and regulatory compliance objectives.
The Accelrys Process Management and Compliance Suite unifies product development and process execution by directly integrating with systems critical to development and manufacturing processes, such as laboratory information management systems (LIMS), enterprise resource planning (ERP), product lifecycle management (PLM), and manufacturing execution systems (MES). The ability to leverage existing applications and infrastructure, combined with the features of the Accelrys Process Management and Compliance Suite, offers organizations for the first time a single, unified source for harmonizing critical-path data and meeting the “right-first-time” needs of downstream manufacturing. The insights gained from the suite enhance reporting, decision making, knowledge management and operational excellence from lab to commercialization.
The Accelrys Process Management and Compliance Suite is the result of Accelrys’ 2012 acquisition of VelQuest Corporation with its industry-leading paperless lab execution and data capture technology. The integrated suite comprises:
- Accelrys Enterprise Platform
- Accelrys Lab Execution System
- Accelrys Electronic Lab Notebook (formerly Symyx Notebook by Accelrys)
- Accelrys Electronic Batch Records
“For too long lab-to-market value chain processes have been managed by an outmoded combination of disconnected point solutions, paper notebooks and home-grown tools, creating a productivity gap that has slowed innovation,” said Ken Rapp, managing director of Accelrys’ analytical, development, quality and manufacturing solutions. “The opportunity we see is to dramatically improve the interoperability between systems, and the ability to move data upstream and downstream.”
Rapp, who founded VelQuest and recently joined Accelrys as part of the acquisition, reports that as recently as four years ago, he noted that R&D organizations using his company’s solutions performed 70% of their development work in-house, and about 30% with outside collaborators.
“Now, it’s the other way around and heading even further away,” says Rapp, as companies look more toward partnerships to accelerate R&D and time-to-market. The new suite was developed in part to help clients manage their constituents, whether they reside in-house or on the opposite side of the globe.
Integration of the Accelrys Process Management and Compliance Suite with the Accelrys Enterprise Platform is intended to enable lifecycle aggregation, analytics and comprehensive reporting across the continuum from discovery to manufacturing. The new offering covers Six Sigma and Quality by Design (QbD) programs and International Conference on Harmonization (ICH) initiatives in pharmacovigilance and risk management.
The Accelrys Process Management and Compliance Suite supports scientists working in early and mid-stage analytical, formulation and process/bioprocess development all the way through to stability, material and release testing during late-stage quality control and commercial production. By ensuring seamless technology transfer at the crucial research, development, pilot and manufacturing handoffs, the suite enables the rapid and accurate transfer of methods, recipes and procedures captured during early development into automated execution. As a result, says Rapp, customers have reported that they are experiencing up to 25% productivity improvement while cutting cycle times in half and reducing compliance risks.
Accelrys Process Management and Compliance Suite
Source: Accelrys Inc.